Liver International · 2015 · 94 citations · 28 references
MedicineRadiologyDiagnostic ImagingHepatologyUltrasonographyChronic Liver DiseaseHepatic PathologyLiver BiopsyLiver DiseaseLiver Function TestsLiver ImagingDiagnostic Performance MetricsHepatic Steatosis AssessmentNon-invasive ExaminationReceiver Operating Characteristic AnalysisSteatosis QuantificationStiffnessStiffness MeasurementThresholds
BACKGROUND & AIMS: Controlled attenuation parameter (CAP) is a non-invasive method for evaluating hepatic steatosis. However, larger skin capsular distance (SCD) can affect the accuracy. The aim of this study was to investigate the impact of SCD on the diagnostic performance of CAP and liver stiffness measurement (LSM). METHODS: Of 101 patients with non-alcoholic fatty liver disease (NAFLD) and 280 patients with chronic hepatitis B (CHB) who underwent liver biopsy were prospectively recruited. CAP, LSM and SCD were performed using FibroScan with M probe. The areas under receiver operating characteristics curves (AUROCs) were calculated to determine the diagnostic efficacy. The optimal thresholds were defined by the maximum Youden index. RESULTS: SCD (B 30.34, P < 0.001) and hepatic steatosis (B 23.04, P < 0.001) were independently associated with CAP by multivariate analysis. The AUROCs were slightly higher for SCD <25 mm compared to those for SCD ≥25 mm for steatosis ≥5% (0.88 vs. 0.81), >33% (0.90 vs. 0.85) and >66% (0.84 vs. 0.72). For SCD <25 mm, the optimal CAP cut-offs for differentiating steatosis ≥5%, >33% and >66% were 255.0 dB/m, 283.5 dB/m and 293.5 dB/m. However, cut-offs were elevated by approximately 60-70 dB/m for SCD ≥25 mm. When stratified by fibrosis grade, LSM was significantly affected by SCD ≥25 mm for advanced fibrosis (≥F3) in NAFLD, but not in CHB. CONCLUSION: CAP is a promising tool for detecting and quantifying hepatic steatosis. SCD ≥25 mm may cause overestimation of steatosis. Similarly, SCD ≥25 mm affects the detection of advanced fibrosis by LSM in NAFLD patients.
28
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Pierre Bédossa, Thierry Poynard · Hepatology · 1996 · 4K citations · Full text
Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis
Gunda Millonig, Frank Reimann, Stephanie Friedrich et al. · Hepatology · 2008 · 596 citations · Full text
Medicine, Radiology, Hepatology +12